In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007–2009 study
about
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureusCoagulase-negative staphylococci.Safety profiles of old and new antimicrobials for the treatment of MRSA infections.Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections.New antibiotics for bad bugs: where are we?Development of novel antibacterial drugs to combat multiple resistant organisms.Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.Dalbavancin and Oritavancin: An Innovative Approach to the Treatment of Gram-Positive Infections.Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method.
P2860
Q27027412-DB427203-5A2A-402C-9FC2-4A8FD292F09EQ30401758-846980AC-3A6A-4D1C-8E13-C8B37E8242BDQ33429168-8D4E368A-AFB9-475A-B4F8-41893CB3ECAFQ36073405-D00B610A-9F54-4096-9C8A-A5E9A8725623Q38132217-C11E1F4B-06E9-4C8F-8FAA-DD1311C3E7B1Q38350301-13172341-5EEF-4D1F-A97C-F7146EE8183BQ38536284-BCBFC8A7-C746-4642-AEEA-5482923D2082Q38615330-CAA66135-A3E1-4B46-8842-B64FA5965CDEQ39042375-766911CD-5FC6-4EDC-B9E4-3F96FE2B3D37Q40252885-0089CE1E-C9EB-4419-A852-81086B4AB4EDQ41687426-A8609C57-B845-4338-BB37-64FFDBC52329
P2860
In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007–2009 study
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2011
@uk
name
In vitro activity of dalbavanc ...... of the CANWARD 2007–2009 study
@en
In vitro activity of dalbavanc ...... of the CANWARD 2007–2009 study
@nl
type
label
In vitro activity of dalbavanc ...... of the CANWARD 2007–2009 study
@en
In vitro activity of dalbavanc ...... of the CANWARD 2007–2009 study
@nl
prefLabel
In vitro activity of dalbavanc ...... of the CANWARD 2007–2009 study
@en
In vitro activity of dalbavanc ...... of the CANWARD 2007–2009 study
@nl
P2093
P1476
In vitro activity of dalbavanc ...... of the CANWARD 2007-2009 study
@en
P2093
Canadian Antimicrobial Resistance Alliance (CARA)
Daryl J Hoban
Heather J Adam
James A Karlowsky
Susan M Poutanen
P304
P356
10.1016/J.DIAGMICROBIO.2010.10.031
P577
2011-03-01T00:00:00Z